価格表
在庫・価格 ： 2025年04月28日 17時18分 現在
| 商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
|---|---|---|---|---|---|---|
|
Anti-CD40 (mouse), mAb (FGK45) データシート |
AG-20B-0036-C100 |
KOMアディポジェン ライフ サイエンシーズ Adipogen Life Sciences |
100 μg | ¥39,000 |
無 (未発注) |
追加 |
在庫・価格 ： 2025年04月28日 17時18分 現在
使用文献
| No. | 文献情報 | 備考 | 参照 |
|---|---|---|---|
| 1 |
Rolink A et al. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 1996 Oct;5(4):319-30 Rolink A et al 1996/01/01 |
 |
|
| 2 |
Turner JG et al. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells. J. Immunol. 2001 Jan;166(1):89-94 Turner JG et al 2001/01/01 |
|
|
| 3 |
Mauri C et al. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process. Nat. Med. 2000 Jun;6(6):673-9 Mauri C et al 2000/01/01 |
|
|
| 4 |
Erlebacher A et al. Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J. Clin. Invest. 2004 Jul;114(1):39-48 Erlebacher A et al 2004/01/01 |
|
|
| 5 |
McGregor CM et al. CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2004 Jun;101(25):9345-50 McGregor CM et al 2004/01/01 |
|
|
| 6 |
Honda K et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005 Apr;434(7034):772-7 Honda K et al 2005/01/01 |
|
|
| 7 |
Greene JA et al. In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN. J. Immunol. 2006 May;176(10):5995-6003 Greene JA et al 2006/01/01 |
|
|
| 8 |
Hellings PW et al. IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling. J. Immunol. 2006 Oct;177(8):5138-44 Hellings PW et al 2006/01/01 |
|
|
| 9 |
Bartholdy C et al. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus. J. Immunol. 2007 Feb;178(3):1662-70 Bartholdy C et al 2007/01/01 |
|
- No.： 1
-
文献情報：
Rolink A et al. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 1996 Oct;5(4):319-30
Rolink A et al
1996/01/01
-
備考：
-
参照：
- No.： 2
-
文献情報：
Turner JG et al. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells. J. Immunol. 2001 Jan;166(1):89-94
Turner JG et al
2001/01/01
-
備考：
-
参照：
- No.： 3
-
文献情報：
Mauri C et al. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process. Nat. Med. 2000 Jun;6(6):673-9
Mauri C et al
2000/01/01
-
備考：
-
参照：
- No.： 4
-
文献情報：
Erlebacher A et al. Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J. Clin. Invest. 2004 Jul;114(1):39-48
Erlebacher A et al
2004/01/01
-
備考：
-
参照：
- No.： 5
-
文献情報：
McGregor CM et al. CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2004 Jun;101(25):9345-50
McGregor CM et al
2004/01/01
-
備考：
-
参照：
- No.： 6
-
文献情報：
Honda K et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005 Apr;434(7034):772-7
Honda K et al
2005/01/01
-
備考：
-
参照：
- No.： 7
-
文献情報：
Greene JA et al. In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN. J. Immunol. 2006 May;176(10):5995-6003
Greene JA et al
2006/01/01
-
備考：
-
参照：
- No.： 8
-
文献情報：
Hellings PW et al. IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling. J. Immunol. 2006 Oct;177(8):5138-44
Hellings PW et al
2006/01/01
-
備考：
-
参照：
- No.： 9
-
文献情報：
Bartholdy C et al. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus. J. Immunol. 2007 Feb;178(3):1662-70
Bartholdy C et al
2007/01/01
-
備考：
-
参照：